Form 4 · Filed Apr 30, 2026, 12:00 PM UTC
DYN/Dyne Therapeutics, Inc.
Rhodes Jason P — director
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
8 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | S | sell | 59,870 | $18 | $1,100,411 | 1,577,432 |
| Apr 28, 2026 | S | sell | 119,115 | $18 | $2,189,334 | 4,939,489 |
| Apr 28, 2026 | S | sell | 1,170 | $18 | $21,505 | 8,512 |
| Apr 28, 2026 | S | sell | 47,082 | $18 | $865,367 | 1,158,944 |
| Apr 28, 2026 | S | sell | 26 | $19 | $494 | 1,577,406 |
| Apr 28, 2026 | S | sell | 52 | $19 | $988 | 4,939,437 |
| Apr 28, 2026 | S | sell | 1 | $19 | $19 | 8,511 |
| Apr 28, 2026 | S | sell | 21 | $19 | $399 | 1,158,923 |
Source: SEC EDGAR raw filing ↗ · Accession 0001577014-26-000006